Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

Writing Group for the Women's Health Initiative Investigators·2002·JAMA: The Journal of the American Medical Association

Cited by (1,144)

Items 401–500 of 1,144

  1. Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies
    Lundh, Andreas, Gøtzsche, Peter C · 2008 · BMC Medical Research Methodology
  2. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women
    Ahmedin Jemal, Elizabeth Ward, Michael J. Thun · 2007 · Breast Cancer Research
  3. Cyclic Estrogen Replacement Improves Cognitive Function in Aged Ovariectomized Rhesus Monkeys
    Peter R. Rapp, John H. Morrison, Jeffrey A. Roberts · 2003 · Journal of Neuroscience
  4. Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo
    Stina Garvin, Karin M. Öllinger, Charlotta Dabrosin · 2005 · Cancer Letters
  5. Postmenopausal syndrome
    PK Dalal, Manu Agarwal · 2015 · Indian Journal of Psychiatry
  6. Compliance with drug therapies for the treatment and prevention of osteoporosis
    Jeffrey S. McCombs, Patrick Thiebaud, Constance McLaughlin-Miley, Jinhai Shi · 2004 · Maturitas
  7. Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women
    Leslie Cho, Melinda Baughman Davis, Islam Y. Elgendy, Kelly Epps, Kathryn J. Lindley, Puja K. Mehta, Erin D. Michos, Margo Minissian, Carl J. Pepine, Viola Vaccarino et al. · 2020 · Journal of the American College of Cardiology
  8. Arterial Imaging Outcomes and Cardiovascular Risk Factors in Recently Menopausal Women
    Sherman Mitchell Harman, Dennis M. Black, Frederick Nicholas Naftolin, Eliot A. Brinton, Matthew Jay Budoff, Marcelle Ivonne Cedars, Paul Nathan Hopkins, Rogerio A. Løbo, JoAnn E. Manson, George R. Merriam et al. · 2014 · Annals of Internal Medicine
  9. Prenatal Diethylstilbestrol Exposure and Risk of Breast Cancer
    Julie R. Palmer, Lauren Anne Wise, Elizabeth Elliott Hatch, Rebecca J. Troisi, Linda T. Titus-Ernstoff, William C. Strohsnitter, Raymond H. Kaufman, Arthur L. Herbst, Kenneth L. Noller, Marianne Hyer et al. · 2006 · Cancer Epidemiology Biomarkers & Prevention
  10. Increased Risk of Recurrence After Hormone Replacement Therapy in Breast Cancer Survivors
    Lars Holmberg, Ole Erik Iversen, C.-M. Rudenstam, Mats L. Hammar, E. Kumpulainen, Janusz Jaśkiewicz, Jacek Jassem, D. Dobaczewska, Hans E. Fjøsne, O Peralta et al. · 2008 · JNCI Journal of the National Cancer Institute
  11. Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists
    Angela H.E.M. Maas, Giuseppe M.C. Rosano, Renata Cífková, Alaide Chieffo, Dorenda van Dijken, Haitham Hamoda, Vijay Kunadian, Ellen T M Laan, Irene V. Lambrinoudaki, Kate Maclaran et al. · 2020 · European Heart Journal
  12. Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women
    Lori J. Mosca, Lawrence J. Appel, Emelia J. Benjamin, Kathy A. Berra, Nisha Chandra‐Strobos, Rosalind P. Fabunmi, Deborah G. Grady, Constance K. Haan, Sharonne N. Hayes, Debra R. Judelson et al. · 2004 · Arteriosclerosis Thrombosis and Vascular Biology
  13. Guidance for the evaluation and treatment of hereditary and acquired thrombophilia
    Scott M. Stevens, Scott C. Woller, Kenneth Alan Bauer, Raj S. Kasthuri, Mary Cushman, Michael Blake Streiff, Wendy Lim, James Demetrios Douketis · 2016 · Journal of Thrombosis and Thrombolysis
  14. Pulmonary embolism
    Samuel Zachary Goldhaber · 2004 · The Lancet
  15. 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
    Jeffrey L. Anderson, Cynthia D. Adams, Elliott Marshall Antman, Charles R. Bridges, Robert M. Califf, Donald E. Casey, William E. Chavey, Francis M. Fesmire, Judith S. Hochman, Thomas N. Levin et al. · 2011 · Circulation
  16. Preventing Osteoporosis-Related Fractures: An Overview
    Margery L S Gass, Bess Dawson‐Hughes · 2006 · The American Journal of Medicine
  17. Epidemiology, treatment and costs of osteoporosis in Germany—the BoneEVA Study
    Bertram Häussler, Holger Gothe, D. Göl, Gerd Glaeske, Ludger Pientka, Dieter Felsenberg · 2006 · Osteoporosis International
  18. Hypopituitarism
    Schneider, Harald Jörn, Aimaretti, Gianluca, Kreitschmann-Andermahr, Ilonka, Stalla, Günter-Karl, Ghigo, Ezio · 2007 · The Lancet
  19. Sex Hormones and Sex Chromosomes Cause Sex Differences in the Development of Cardiovascular Diseases
    Arthur P. Arnold, Lisa Ann Cassis, Mansoureh Eghbali, Karen Reue, Kathryn L. Sandberg · 2017 · Arteriosclerosis Thrombosis and Vascular Biology
  20. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society: Retracted
    2004 · Menopause The Journal of The North American Menopause Society
  21. Sexual Orientation, Health Risk Factors, and Physical Functioning in the Nurses' Health Study II
    Patricia Case, Sydney Bryn Austin, David J. Hunter, JoAnn E. Manson, Susan Malspeis, Walter Churchill Willett, Donna L. Spiegelman · 2004 · Journal of Women s Health
  22. Prevalence and Impact of Vaginal Symptoms Among Postmenopausal Women
    Nanette F. Santoro, Janne Komi · 2009 · The Journal of Sexual Medicine
  23. Meta-analysis of vascular and neoplastic events associated with tamoxifen
    Ronald Scott Braithwaite, Rowan T. Chlebowski, Joseph Lau, Suzanne George, Rachel Hess, Nananda F. Col · 2003 · Journal of General Internal Medicine
  24. Blood Pressure, C-Reactive Protein, and Risk of Future Cardiovascular Events
    Gavin J. Blake, Nader Rifai, Julie E. Buring, Paul M. Ridker · 2003 · Circulation
  25. 17β-Estradiol Reduces Cardiomyocyte Apoptosis In Vivo and In Vitro via Activation of Phospho-Inositide-3 Kinase/Akt Signaling
    Richard D. Patten, Isaac Pourati, Mark J. Aronovitz, Jason Baur, Flore Celestin, Xin Chen, Ashour Michael, Syed Haq, Simone Nuedling, Christian Grohé et al. · 2004 · Circulation Research
  26. Mortality in Patients with Pituitary Disease
    Sherlock, Mark, Ayuk, John, Tomlinson, Jeremy W., Toogood, Andrew A., Aragon-Alonso, Aurora, Sheppard, Michael C., Bates, Andrew S., Stewart, Paul M. · 2010 · Endocrine Reviews
  27. Pregnancy and Reproductive Risk Factors for Cardiovascular Disease in Women
    Anna C. O’Kelly, Erin D. Michos, CHRISANDRA L. SHUFELT, Jane V. Vermunt, Margo Minissian, Odayme Quesada, Graeme Neil Smith, Janet Wilson Rich-Edwards, Vesna D. Garovic, Samar R. El Khoudary et al. · 2022 · Circulation Research
  28. Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance
    Zhu, Lin, Brown, William C., Cai, Qing, Krust, Andrée, Chambon, Pierre, McGuinness, Owen P., Stafford, John M. · 2013 · Diabetes
  29. Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial
    Nicola Cherry, Kyle Gilmour, Philip C Hannaford, Anthony Michael Heagerty, Mohammed Amjed Khan, Henry Charles Kitchener, Roseanne McNamee, Max Elstein, Clifford R. Kay, Mourad W. Seif et al. · 2002 · The Lancet
  30. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status—A meta‐analysis
    Reiko Suzuki, Nicola Orsini, Shigehira Saji, Timothy J. Key, Alicja Wolk · 2008 · International Journal of Cancer
  31. Prevention of Brca1 -Mediated Mammary Tumorigenesis in Mice by a Progesterone Antagonist
    Aleksandra Jovanovic Poole, Ying Li, Yoon Hee Kim, Suh‐Chin J. Lin, Wen‐Hwa Lee, Eva Y.-H.P. Lee · 2006 · Science
  32. Systems for grading the quality of evidence and the strength of recommendations II: Pilot study of a new system
    David C. Atkins, Peter A. Briss, Martin Eccles, Signe Agnes Flottorp, Gordon Henry Guyatt, Robin Harbour, Suzanne Rose Hill, Roman Jaeschke, Alessandro Liberati, Nicola Magrini et al. · 2005 · BMC Health Services Research
  33. Effect of Osteoporosis Treatment on Mortality: A Meta-Analysis
    Mark J Bolland, Andrew B. Grey, Greg D. Gamble, Ian R. Reid · 2010 · The Journal of Clinical Endocrinology & Metabolism
  34. Understanding the Divergent Data on Postmenopausal Hormone Therapy
    Francine Grodstein, Thomas B. Clarkson, JoAnn E. Manson · 2003 · New England Journal of Medicine
  35. Estrogen and skin: The effects of estrogen, menopause, and hormone replacement therapy on the skin
    Glenda K. Hall, Tania J. Phillips · 2005 · Journal of the American Academy of Dermatology
  36. Sexual Activity and Cardiovascular Disease
    Glenn N. Levine, Elaine E. Steinke, Faisal G. Bakaeen, Biykem Bozkurt, Melvin D. Cheitlin, JAMIE BETH CONTI, Elyse Foster, Tiny Jaarsma, Robert Alan Kloner, Richard A. Lange et al. · 2012 · Circulation
  37. Early menopause predicts future coronary heart disease and stroke
    Melissa Wellons, Pamela Ouyang, Pamela J. Schreiner, David M. Herrington, Dhananjay M. Vaidya · 2012 · Menopause The Journal of The North American Menopause Society
  38. Physical activity decreases cardiovascular disease risk in women
    Oguma, Yuko, Shinoda-Tagawa, Tomoko · 2004 · American Journal of Preventive Medicine
  39. Hot Flashes and Subclinical Cardiovascular Disease
    Rebecca C. Thurston, Kim Sutton-Tyrrell, Susan A. Everson‐Rose, Rachel Hess, Karen A. Matthews · 2008 · Circulation
  40. Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial
    Rowan T. Chlebowski, Ann G. Schwartz, Heather A. Wakelee, Garnet L. Anderson, Marcia L. Stefanick, JoAnn E. Manson, Rebecca J. Rodabough, Jason W. Chien, Jean Wactawski‐Wende, Margery L S Gass et al. · 2009 · The Lancet
  41. Management of Menopausal Symptoms
    Carolyn J. Crandall, Jaya M. Mehta, JoAnn E. Manson · 2023 · JAMA
  42. The marketing of a disease: female sexual dysfunction
    Ray N Moynihan · 2005 · BMJ
  43. Prevention and management of osteoporosis
    Michael R. McClung · 2003 · Best Practice & Research Clinical Endocrinology & Metabolism
  44. Selective estrogen receptor modulation
    Virgil Craig Jordan · 2004 · Cancer Cell
  45. Sex differences in resident immune cell phenotype underlie more efficient acute inflammatory responses in female mice
    Ramona S. Scotland, Melanie J. Stables, Shimona Madalli, Peter Hamilton Watson, Derek William Gilroy · 2011 · Blood
  46. Effects of the Phytoestrogen Genistein on Bone Metabolism in Osteopenic Postmenopausal Women
    Herbert Ryan Marini, Letteria Minutoli, Francesca Polito, Alessandra Bitto, Domenica Altavilla, Marco Atteritano, Agostino Gaudio, Susanna Mazzaferro, Alessia Frisina, Nicola Frisina et al. · 2007 · Annals of Internal Medicine
  47. Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects
    Jolanda M. H. Elbers, Erik J. Giltay, Tom Teerlink, Peter G Scheffer, Henk Asscheman, Jacob C. Seidell, Louis J. Gooren · 2003 · Clinical Endocrinology
  48. Menopausal Symptoms and Treatment-Related Effects of Estrogen and Progestin in the Womenʼs Health Initiative
    Vanessa M. Barnabei, Barbara B. Cochrane, Aaron K. Aragaki, Ingrid E. Nygaard, R Stan Williams, Peter G. McGovern, Ronald L. Young, Ellen C. Wells, Mary Jo OʼSullivan, Bertha H. Chen et al. · 2005 · Obstetrics and Gynecology
  49. Postmenopausal Hormone Replacement Therapy and the Primary Prevention of Cardiovascular Disease
    Linda L. Humphrey, Benjamin K S Chan, Harold C. Sox · 2002 · Annals of Internal Medicine
  50. Effect of Different Antilipidemic Agents and Diets on Mortality
    Marco Studer, Matthias Briel, Bernd M. Leimenstoll, Tracy R. Glass, Heiner C. Bucher · 2005 · Archives of Internal Medicine
  51. Estrogen and ischemic neuroprotection: an integrated view
    Louise D. McCullough, Patricia D. Hurn · 2003 · Trends in Endocrinology and Metabolism
  52. Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial
    Thomas J. Guttuso · 2003 · Obstetrics and Gynecology
  53. Gender differences in the effects of cardiovascular drugs
    Juan Luis Tamargo, Giuseppe M.C. Rosano, Thomas Walther, Juan Duarte, Alexander Niessner, JC Kaski, Claudio Ceconi, Heinz Drexel, Keld P. Kjeldsen, Gianluigi Savarese et al. · 2016 · European Heart Journal - Cardiovascular Pharmacotherapy
  54. When and how can real world data analyses substitute for randomized controlled trials?
    Franklin, Jessica M., Schneeweiss, Sebastian · 2017 · Clinical Pharmacology & Therapeutics
  55. Changes in the Use of Postmenopausal Hormone Therapy after the Publication of Clinical Trial Results
    Jennifer S. Haas, Celia Patricia Kaplan, Eric P. Gerstenberger, Karla M. Kerlikowske · 2004 · Annals of Internal Medicine
  56. Efficacy of phytoestrogens for menopausal symptoms: a meta-analysis and systematic review
    M-n. Chen, Chi‐Chen Lin, C.Y. Liu · 2014 · Climacteric
  57. Genetics of osteoporosis from genome-wide association studies: advances and challenges
    John Brent Richards, Hou‐Feng Zheng, Tim D. Spector · 2012 · Nature Reviews Genetics
  58. The biological role of estrogen receptors α and β in cancer
    Sandra Timm Pearce, Virgil Craig Jordan · 2004 · Critical Reviews in Oncology/Hematology
  59. Moderators of Treatment Outcomes: Clinical, Research, and Policy Importance
    Kraemer, Helena C., Frank, Ellen, Kupfer, David J. · 2006 · JAMA
  60. Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis
    Chwalisz, Kristof, Perez, Maria Claudia, DeManno, Deborah, Winkel, Craig, Schubert, Gerd, Elger, Walter · 2005 · Endocrine Reviews
  61. Twenty years and still counting: including women as participants and studying sex and gender in biomedical research
    Carolyn M. Mazure, Daniel P. Jones · 2015 · BMC Women s Health
  62. Effects of Combination Estrogen Plus Progestin Hormone Treatment on Cognition and Affect
    Susan M. Resnick, Pauline M. Maki, Stephen R. Rapp, Mark Andrew Espeland, Robert L. Brunner, Laura H. Coker, Iris A. Granek, Patricia E. Hogan, Judith K. Ockene, Sally Ann Shumaker · 2006 · The Journal of Clinical Endocrinology & Metabolism
  63. Ovarian Hormones and Migraine Headache: Understanding Mechanisms and Pathogenesis—Part 2
    Vincent T. Martin, Michael M. Behbehani · 2006 · Headache The Journal of Head and Face Pain
  64. The endocrine system and ageing
    HS Chahal, WM Drake · 2007 · The Journal of Pathology
  65. Lifestyle and Demographic Factors in Relation to Vasomotor Symptoms: Baseline Results from the Study of Women's Health Across the Nation
    Ellen B. Gold, Gladys Block, Sybil L. Crawford, Laurie Lachance, Gordon FitzGerald, Heidi L. Miracle-McMahill, Sheryl Sherman · 2004 · American Journal of Epidemiology
  66. Environmental pollutants and breast cancer.
    Julia Green Brody, Ruthann A. Rudel · 2003 · Environmental Health Perspectives
  67. European Code Against Cancer and scientific justification: third version (2003)
    Peter Boyle, Philippe Autier, Harry G M M Bartelink, Jose M Baselga, Paolo Boffetta, John Burn, Henry J. G. Burns, Lars Porskjær Christensen, L. Denis, Mario A. Dicato et al. · 2003 · Annals of Oncology
  68. Culture and symptom reporting at menopause
    Melissa K. Melby, Margaret M. Lock, Patricia Kaufert · 2005 · Human Reproduction Update
  69. Matrix metalloproteinases A review of their structure and role in acute coronary syndrome
    C Jones · 2003 · Cardiovascular Research
  70. Treatment of Vasomotor Symptoms of Menopause with Black Cohosh, Multibotanicals, Soy, Hormone Therapy, or Placebo
    Katherine M. Newton, Susan D. Reed, Andrea Z. LaCroix, Louis C. Grothaus, Kelly J. Ehrlich, Jane Guiltinan · 2006 · Annals of Internal Medicine
  71. Addressing the Soy and Breast Cancer Relationship: Review, Commentary, and Workshop Proceedings
    Mark J. Messina, Worta McCaskill‐Stevens, Johanna W. Lampe · 2006 · JNCI Journal of the National Cancer Institute
  72. Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland
    Manfred Beleut, Renuga Devi Rajaram, Marian Čaikovski, Ayyakkannu Ayyanan, Davide Germano, Yongwon Choi, Pascal Schneider, Cathrin Brisken · 2010 · Proceedings of the National Academy of Sciences
  73. Cardiac Toxicity in Breast Cancer Survivors: Review of Potential Cardiac Problems
    Brian Bird, Sandra M. Swain · 2008 · Clinical Cancer Research
  74. Obesity and fractures in postmenopausal women
    Melissa Orlandin Premaor, Lesley Pilbrow, Carol Tonkin, Richard Anthony Parker, Juliet Elizabeth Compston · 2009 · Journal of Bone and Mineral Research
  75. Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005.
    P. Ridker, José L Torres · 2006 · Journal of the American Medical Association (JAMA)
  76. Osteoporosis Prevention, Screening, and Treatment: A Review
    Juliana M. Kling, Bart Lyman Clarke, Nicole P. Sandhu · 2014 · Journal of Women s Health
  77. Effect of Estrogen Therapy on Gallbladder Disease
    Dominic J. Cirillo · 2005 · JAMA
  78. Clinical Epidemiology: How to Do Clinical Practice Research
    Robert Brian Haynes, David L. Sackett, Gordon Henry Guyatt, Peter Tugwell · 2005 · Medical Entomology and Zoology
  79. Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification
    Terence M. Doherty, Lorraine A. Fitzpatrick, Daisuke Inoue, Jian-Hua Qiao, Michael C. Fishbein, Robert Detrano, Prediman K. Shah, Tripathi B. Rajavashisth · 2004 · Endocrine Reviews
  80. The Controversial History of Hormone Replacement Therapy
    Angelo Cagnacci, Martina Venier · 2019 · Medicina
  81. Steroid hormones and neurosteroids in normal and pathological aging of the nervous system
    Michaël Schumacher, Sébastien Weill‐Engerer, Philippe Lière, F. Robert, Robin J.M. Franklin, Luis Miguel García‐Segura, Jeremy J. Lambert, Willy Mayo, Roberto Cosimo Melcangi, Á. Párducz et al. · 2003 · Progress in Neurobiology
  82. Early Diagnosis of Alzheimer's Disease: Clinical and Economic Benefits
    Bennett P. Leifer · 2003 · Journal of the American Geriatrics Society
  83. Testosterone and insulin resistance in the metabolic syndrome and T2DM in men
    Rao, Preethi M., Kelly, Daniel M., Jones, T. Hugh · 2013 · Nature Reviews Endocrinology
  84. Hormone Therapy: Physiological Complexity Belies Therapeutic Simplicity
    Judith L. Turgeon, Donald Patrick McDonnell, Kathryn Ann Martin, Phyllis M. Wise · 2004 · Science
  85. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health
    T. J. de Villiers, Amos Pines, Nick Panay, Marco Gambacciani, David F. Archer, Rod Baber, Susan R. Davis, Anne Gompel, Victor W. Henderson, R. Langer et al. · 2013 · Climacteric
  86. Commonly Used Types of Postmenopausal Estrogen for Treatment of Hot Flashes: Scientific Review
    Nelson, Heidi D. · 2004 · JAMA
  87. Sex differences in mechanisms of arterial stiffness
    Jennifer J. DuPont, Rachel M. Kenney, Ayan R. Patel, Iris Zamir Jaffe · 2019 · British Journal of Pharmacology
  88. Effects of aging on angiogenesis
    Lähteenvuo, Johanna, Rosenzweig, Anthony · 2012 · Circulation Research
  89. A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis
    Matt Stevenson, Myfawny Lloyd Jones, Enrico De Nigris, N Brewer, Sarah Davis, Jeremy E. Oakley · 2005 · Health Technology Assessment
  90. Sex Steroids and Cardiovascular Outcomes in Transgender Individuals: A Systematic Review and Meta‐Analysis
    S. Maraka, N. Ospina, R. Rodríguez-Gutiérrez, Caroline J. Davidge-Pitts, T. Nippoldt, L. Prokop, H. Murad · 2017 · Journal of Clinical Endocrinology and Metabolism
  91. Gut, inflammation and osteoporosis: Basic and clinical concepts
    Tilg, H, Moschen, A R, Kaser, A, Pines, A, Dotan, I · 2008 · Gut
  92. Red alert for women's heart: the urgent need for more research and knowledge on cardiovascular disease in women: Proceedings of the Workshop held in Brussels on Gender Differences in Cardiovascular disease, 29 September 2010
    Angela H.E.M. Maas, Yvonne T. van der Schouw, Vera Regitz‐Zagrosek, Eva Swahn, Yolande Appelman, Gerard Pasterkamp, Hugo Ten Cate, P. M. Nilsson, Menno Volkert Huisman, H. C. G. Stam et al. · 2011 · European Heart Journal
  93. Gender and the renin–angiotensin–aldosterone system
    Kimiaki Komukai, Seibu Mochizuki, Michihiro Yoshimura · 2010 · Fundamental and Clinical Pharmacology
  94. The Pathophysiology and Treatment of Osteoporosis
    Matthew T. Drake, Bart Lyman Clarke, Edward Michael Lewiecki · 2015 · Clinical Therapeutics
  95. Dietary n-3 Fatty Acids Decrease Osteoclastogenesis and Loss of Bone Mass in Ovariectomized Mice
    Dongxu Sun, Aparna Krishnan, Khaliquz Zaman, Richard A Lawrence, Arunabh Bhattacharya, Gabriel Fernandes · 2003 · Journal of Bone and Mineral Research
  96. Mortality associated with hormone replacement therapy in younger and older women
    Shelley R. Salpeter, Judith M. E. Walsh, Elizabeth Greyber, Thomas M. Ormiston, E. E. Salpeter · 2004 · Journal of General Internal Medicine
  97. Estrogen receptors alpha and beta in bone
    Aysha B. Khalid, Susan A. Krum · 2016 · Bone
  98. Sex differences in cardiovascular ageing
    Allison A. Merz, Susan C. Cheng · 2016 · Heart
  99. Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy
    Valerie Beral, GILLIAN K. REEVES, Diana Bull, J. Green, for the Million Women Study Collaborators · 2011 · JNCI Journal of the National Cancer Institute
  100. Phytoestrogens for menopausal vasomotor symptoms
    Anne E. Lethaby, Jane Marjoribanks, Fredi Kronenberg, Helen Roberts, John Eden, Julie Brown · 2013 · Cochrane Database of Systematic Reviews